Gossamer Bio Inc Revenue per Employee (GOSS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gossamer Bio Inc   (NASDAQ: GOSS)
 

Gossamer Bio Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Gossamer Bio Inc 's Revenue per employee fell on a trailing twelve month basis to $ 328,926, below the company average number of $376,720.
Within the Healthcare sector Employees of 282 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 2282, from total ranking in previous quarter at 2822. Gossamer Bio Inc has 162 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GOSS Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -19.59 % 71.45 % 47.13 % 40.23 % -88.01 %
Sales per Employee (TTM) $ 328,926 342,821 299,204 271,920 248,377
GOSS's Total Ranking # 2282 # 2822 # 2723 # 2877 # 1113
Seq. Revenue Change -45.51 % 22.87 % 3.8 % 15.71 % 16.18 %

GOSS Company Profile >> Back to GOSS Efficiency Comparisons >> Compare GOSS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 131
Healthcare Sector # 283
Overall Market # 2282

Revenue per Employee Statistics
High Average Low
$ 769,074 $ 376,720 $ 248,377
(Mar 31 2025)   (Jun 30 2025)



Financial Statements
Gossamer Bio Inc 's Revenue MRQ $ 9 Millions Visit GOSS's Income Statement
Gossamer Bio Inc 's Revenues TTM $ 53 Millions Visit GOSS's aggregate revenue growth
What are GOSS's Sales? Visit GOSS's Sales by Segment




Other Ratios
Gossamer Bio Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GOSS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GOSS's Competitors
Revenue per Employee for GOSS's Suppliers
Revenue per Employee for GOSS's Customers

You may also want to know
GOSS's Sales Growth Rates GOSS's Pe Price to earnings ratio GOSS's Receivables Turnover Ratio GOSS's Stock Quote
GOSS's Net Income Growth Rates GOSS's Ps Price to Sales ratio GOSS's Sales per Employee GOSS's Asset Turnover Ratio
GOSS's Net Margin GOSS's Pb Price to Book ratio GOSS's Financial Strength Ratios GOSS's Dividend Payout Ratio
Date modified: 2026-09-02T20:53:41+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Macrogenics Inc   572,266.21 $ 167.674  Million 293 
Cardiff Lexington Corporation  567,380.00 $ 10.213  Million 18 
Embecta Corp   551,189.19 $ 1,019.700  Million 1,850 
Iridex Corp  548,860.22 $ 51.044  Million 93 
Henry Schein Inc   544,080.00 $ 13,602.000  Million 25,000 
Enanta Pharmaceuticals Inc  543,816.67 $ 65.258  Million 120 
Instil Bio Inc   527,529.41 $ 8.968  Million 17 
Globus Medical Inc   524,155.67 $ 3,144.934  Million 6,000 
10x Genomics Inc   523,400.68 $ 616.566  Million 1,178 
Iradimed Corporation  520,114.23 $ 86.339  Million 166 
Alpha Pro Tech Ltd   505,723.58 $ 62.204  Million 123 
Angiodynamics Inc   502,731.01 $ 317.726  Million 632 
Biofrontera Inc   499,521.74 $ 45.956  Million 92 
Accuray Incorporated  495,467.24 $ 400.833  Million 809 
Resmed Inc   495,001.76 $ 5,628.170  Million 11,370 
Adaptive Biotechnologies Corporation  493,719.55 $ 308.081  Million 624 
Viatris Inc   491,243.33 $ 14,737.300  Million 30,000 
Invivyd Inc   478,401.64 $ 58.365  Million 122 
Maravai Lifesciences Holdings Inc   477,898.85 $ 207.886  Million 435 
Moderna Inc   474,042.55 $ 2,228.000  Million 4,700 
Guardant Health Inc   472,108.94 $ 1,183.105  Million 2,506 
Neuropace Inc   471,866.03 $ 98.620  Million 209 
Skinhealth Systems Inc   471,817.29 $ 289.224  Million 613 
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 
Stryker Corp  461,375.00 $ 25,837.000  Million 56,000 
Atara Biotherapeutics Inc   460,857.14 $ 6.452  Million 14 
Glaukos Corp  457,066.73 $ 500.031  Million 1,094 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.